GeneDx Holdings Corp. WGS

88.40 (0.08) (0.09%) as of 25 Sep
Market cap
$2.6B
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

0.84% (7.60%) (30.42%) (40.80%)
ROA
0.46% (4.46%) (16.33%) (22.50%)
ROIC
3.30% (4.42%) (22.89%) (27.70%)
Return on Tangible Assets
1.08% (10.25%) (33.38%) (47.05%)
Average Days of Receivables
55.30 63.49 63.43 67.16
Free Cash Flow per Share
0.54 0.50 (0.98) (2.55)
Free Cash Flow
15.47 14.26 (28.65) (75.80)
Capital Expenditures
(17.72) (19.02) (19.34) (27.09)
Piotroski F-Score
8.00 6.00 3.00 4.00
Other line items
Cash ROIC
6.65% 6.31% (1.79%) (10.29%)
Accounts Receivable Turnover
8.09 7.63 7.20 6.90
Accounts Payable Turnover
2.29 2.92 3.05 3.05
Inventory Turnover
11.44 10.52 10.82 9.36
Average Days of Payables
150.49 162.64 126.10 110.38
Days of Inventory on Hand
31.60 39.36 33.15 46.73
Tax Rate
(0.17) (0.01) 0.00 0.00
Research and Development Expense of Revenue
14.69% 16.85% 17.90% 18.45%
Selling, General and Administrative Expense of Revenue
52.48% 55.95% 59.49% 64.38%
Share Based Compensation of Revenue
6.27% 7.52% 8.40% 7.86%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
15.93 (1.58) 0.12 0.46
Depreciation/Fixed assets
0.56 0.55 0.53 0.49
Capex/Depreciation
(0.74) (0.75) (0.73) (1.01)
Revenue per Share
13.97 14.93 15.09 15.30
Operating CF per Share
1.15 1.16 (0.32) (1.64)
Capex per Share
(0.62) (0.66) (0.66) (0.91)
Capex to Sales
0.04 0.04 0.04 0.06
Net Profit Margin
0.52% (4.92%) (17.58%) (23.40%)

Fold the line items

Columns are period end dates